Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
23.66 (1y: +21%)
Market Cap 1.11 B P/E(ttm) 177.70
Enterprise Value 1.13 B P/B 1.90
WMGI- NAS (USA)
Wright Medical Group, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$23.66
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry		 vs
history
Cash to Debt 1.284
WMGI's Cash to Debt is ranked lower than
68% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. WMGI: 1.284 )
WMGI' s 10-Year Cash to Debt Range
Min: 0.12   Max: No Debt
Current: 1.28
Equity to Asset 0.466
WMGI's Equity to Asset is ranked lower than
58% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. WMGI: 0.466 )
WMGI' s 10-Year Equity to Asset Range
Min: -1.02   Max: 0.78
Current: 0.47
-1.02
0.78
Interest Coverage 2.4
WMGI's Interest Coverage is ranked lower than
76% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 420.30 vs. WMGI: 2.4 )
WMGI' s 10-Year Interest Coverage Range
Min: 1   Max: No Debt
Current: 2.4
F-Score: 5
Z-Score: 2.92
M-Score: -2.56
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating margin (%) 5.00
WMGI's Operating margin (%) is ranked lower than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. WMGI: 5.00 )
WMGI' s 10-Year Operating margin (%) Range
Min: -15.6   Max: 13.2
Current: 5
-15.6
13.2
Net-margin (%) 1.1
WMGI's Net-margin (%) is ranked lower than
65% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. WMGI: 1.1 )
WMGI' s 10-Year Net-margin (%) Range
Min: -25.1   Max: 12.5
Current: 1.1
-25.1
12.5
ROE (%) 1
WMGI's ROE (%) is ranked lower than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. WMGI: 1 )
WMGI' s 10-Year ROE (%) Range
Min: -1.3   Max: 12.2
Current: 1
-1.3
12.2
ROA (%) 0.6
WMGI's ROA (%) is ranked lower than
62% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. WMGI: 0.6 )
WMGI' s 10-Year ROA (%) Range
Min: -18.6   Max: 9.1
Current: 0.6
-18.6
9.1
ROC (Joel Greenblatt) (%) 6.30
WMGI's ROC (Joel Greenblatt) (%) is ranked lower than
60% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. WMGI: 6.30 )
WMGI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -27   Max: 21
Current: 6.3
-27
21
Revenue Growth (%) -1.3
WMGI's Revenue Growth (%) is ranked higher than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. WMGI: -1.3 )
WMGI' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 10.9
Current: -1.3
0
10.9
EBITDA Growth (%) 1.3
WMGI's EBITDA Growth (%) is ranked higher than
76% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: -1.10 vs. WMGI: 1.3 )
WMGI' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 26
Current: 1.3
0
26
EPS Growth (%) -18.7
WMGI's EPS Growth (%) is ranked lower than
96% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. WMGI: -18.7 )
WMGI' s 10-Year EPS Growth (%) Range
Min: 0   Max: 99
Current: -18.7
0
99
ยป WMGI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

WMGI Guru Trades in Q2 2012

Jim Simons 55,194 sh (New)
Paul Tudor Jones 327,800 sh (+111.76%)
Joel Greenblatt 34,444 sh (+106.38%)
Steven Cohen 295,000 sh (+78.79%)
John Keeley 1,012,363 sh (+17.22%)
Chuck Royce 224,776 sh (+2.28%)
Mario Gabelli 211,000 sh (unchged)
Jeremy Grantham Sold Out
Ken Fisher 1,731,342 sh (-1.89%)
Michael Price 500,000 sh (-19.99%)
» More
Q3 2012

WMGI Guru Trades in Q3 2012

Jeremy Grantham 11,900 sh (New)
Paul Tudor Jones 473,300 sh (+44.39%)
Ken Fisher 2,139,232 sh (+23.56%)
John Keeley 1,076,800 sh (+6.37%)
Chuck Royce 226,276 sh (+0.67%)
Mario Gabelli 211,000 sh (unchged)
Michael Price 500,000 sh (unchged)
Jim Simons Sold Out
Joel Greenblatt Sold Out
Steven Cohen 243,500 sh (-17.46%)
» More
Q4 2012

WMGI Guru Trades in Q4 2012

Joel Greenblatt 45,167 sh (New)
Steven Cohen 466,100 sh (+91.42%)
Ken Fisher 2,484,437 sh (+16.14%)
John Keeley 1,094,950 sh (+1.69%)
Mario Gabelli 211,000 sh (unchged)
Michael Price 500,000 sh (unchged)
Chuck Royce Sold Out
Paul Tudor Jones 115,100 sh (-75.68%)
» More
Q1 2013

WMGI Guru Trades in Q1 2013

Jim Simons 256,527 sh (New)
John Keeley 1,222,950 sh (+11.69%)
Mario Gabelli 211,000 sh (unchged)
Ken Fisher 2,467,229 sh (-0.69%)
Paul Tudor Jones 100,000 sh (-13.12%)
Michael Price 405,758 sh (-18.85%)
Steven Cohen 365,859 sh (-21.51%)
Joel Greenblatt 29,615 sh (-34.43%)
» More
» Details

Insider Trades

Latest Guru Trades with WMGI

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Reduce -34.43%0.02%$20.83 - $24.37 $ 23.666%29615
Joel Greenblatt 2012-12-31 New Buy0.06%$19.67 - $22.19 $ 23.6614%45167
Joel Greenblatt 2012-09-30 Sold Out 0.05%$18.25 - $22.47 $ 23.6616%0
Joel Greenblatt 2012-06-30 Add 106.38%0.03%$18.02 - $21.21 $ 23.6620%34444
Joel Greenblatt 2012-03-31 New Buy0.03%$16.06 - $19.56 $ 23.6645%16690
Michael Price 2011-12-31 Add 25.96%0.35%$13.58 - $18.33 $ 23.6647%655000
John Keeley 2011-12-31 Add 1433.33%0.24%$13.58 - $18.33 $ 23.6647%766663
John Keeley 2011-09-30 New Buy0.02%$13.56 - $18.3 $ 23.6654%50000
George Soros 2011-09-30 Sold Out 0.0022%$13.56 - $18.3 $ 23.6654%0
Michael Price 2011-06-30 New Buy1.27%$14.23 - $17.14 $ 23.6654%581518
Mario Gabelli 2011-06-30 Add 282%0.02%$14.23 - $17.14 $ 23.6654%191000
George Soros 2011-06-30 Reduce -39.64%$14.23 - $17.14 $ 23.6654%10200
PRIMECAP Management 2011-06-30 Sold Out $14.23 - $17.14 $ 23.6654%0
Mario Gabelli 2011-03-31 Reduce -63.77%0.02%$14.5 - $17.41 $ 23.6648%50000
PRIMECAP Management 2011-03-31 Add 74.76%0.02%$14.5 - $17.41 $ 23.6648%2106328
George Soros 2011-03-31 New Buy$14.5 - $17.41 $ 23.6648%16900
Mario Gabelli 2010-09-30 Add 530%0.01%$13.22 - $17.49 $ 23.6658%126000
Jean-Marie Eveillard 2010-06-30 Sold Out $16.07 - $19.27 $ 23.6634%0
Mario Gabelli 2010-06-30 Reduce -80.39%$16.07 - $19.27 $ 23.6634%20000
PRIMECAP Management 2010-03-31 Add 3761.6%0.03%$15.79 - $19.17 $ 23.6634%965400
Jean-Marie Eveillard 2010-03-31 New Buy$15.79 - $19.17 $ 23.6634%200000
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 177.70
WMGI's P/E(ttm) is ranked lower than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. WMGI: 177.70 )
WMGI' s 10-Year P/E(ttm) Range
Min: 18.42   Max: 986
Current: 177.7
18.42
986
P/B 1.90
WMGI's P/B is ranked higher than
64% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. WMGI: 1.90 )
WMGI' s 10-Year P/B Range
Min: 1.09   Max: 5.09
Current: 1.9
1.09
5.09
P/S 2.10
WMGI's P/S is ranked higher than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. WMGI: 2.10 )
WMGI' s 10-Year P/S Range
Min: 0.96   Max: 4.75
Current: 2.1
0.96
4.75
PFCF 20.40
WMGI's PFCF is ranked higher than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 18.60 vs. WMGI: 20.40 )
WMGI' s 10-Year PFCF Range
Min: 12.24   Max: 1004.67
Current: 20.4
12.24
1004.67
EV-to-EBIT 47.6
WMGI's EV-to-EBIT is ranked lower than
64% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. WMGI: 47.6 )
WMGI' s 10-Year EV-to-EBIT Range
Min: 11.2   Max: 763.6
Current: 47.6
11.2
763.6
PEG 177.7
WMGI's PEG is ranked lower than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.23 vs. WMGI: 177.7 )
WMGI' s 10-Year PEG Range
Min: 1.2   Max: 185
Current: 177.7
1.2
185
Shiller P/E 149.4
WMGI's Shiller P/E is ranked higher than
77% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 23.60 vs. WMGI: 149.4 )
WMGI' s 10-Year Shiller P/E Range
Min: 28.26   Max: 155.1
Current: 149.4
28.26
155.1

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 6.6
WMGI's Price/Net Current Asset Value is ranked higher than
63% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. WMGI: 6.6 )
WMGI' s 10-Year Price/Net Current Asset Value Range
Min: 3.7   Max: 14.3
Current: 6.6
3.7
14.3
Price/Tangible Book 2.1
WMGI's Price/Tangible Book is ranked higher than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. WMGI: 2.1 )
WMGI' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 5
Current: 2.1
1.5
5
Price/DCF (Projected) 2
WMGI's Price/DCF (Projected) is ranked higher than
92% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. WMGI: 2 )
WMGI' s 10-Year Price/DCF (Projected) Range
Min: 1.8   Max: 3.5
Current: 2
1.8
3.5
Price/Median PS Value 0.8
WMGI's Price/Median PS Value is ranked higher than
69% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. WMGI: 0.8 )
WMGI' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 1.8
Current: 0.8
0.5
1.8
Price/Peter Lynch Fair Value 35.3
WMGI's Price/Peter Lynch Fair Value is ranked lower than
74% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. WMGI: 35.3 )
WMGI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 2.7   Max: 100.6
Current: 35.3
2.7
100.6
Price/Graham Number 4
WMGI's Price/Graham Number is ranked lower than
82% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. WMGI: 4 )
WMGI' s 10-Year Price/Graham Number Range
Min: 1.5   Max: 18.6
Current: 4
1.5
18.6
Earnings Yield (Greenblatt) 2.10
WMGI's Earnings Yield (Greenblatt) is ranked higher than
57% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. WMGI: 2.10 )
WMGI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 8.9
Current: 2.1
0.1
8.9
Forward Rate of Return (Yacktman) 5.09
WMGI's Forward Rate of Return (Yacktman) is ranked higher than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. WMGI: 5.09 )
WMGI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -12.8   Max: 17.8
Current: 5.09
-12.8
17.8

Business Description

Wright Medical Group, Inc. is a Delaware Corporation. The Company through Wright Medical Technology, Inc. (WMT) and other operating subsidiaries (Wright), is a global orthopaedic medical device company specializing in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction. It is a provider of surgical solutions for the foot and ankle market. Reconstructive devices are used to replace or repair knee, hip and other joints and bones that have deteriorated or have been damaged through disease or injury. Biologics are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and their patients. Within these markets, it focuses on the higher-growth sectors of the orthopaedic industry, such as the foot and ankle market, as well as on the integration of its biologic products into reconstructive procedures and other orthopaedic applications. Foot and ankle reconstruction includes implants and other devices to replace or reconstruct injured or diseased joints and bones in the foot and ankle. The Company's biologic products are primarily used in extremity-related procedures as well as in trauma and tumor induced voids of the long bones, joint replacements and some spine procedures. Biologic products provide a lower morbidity solution to 'autografting,' a procedure that involves harvesting a patient's own bone or soft tissue and transplanting it to a different site. The Company's flagship, PRO-DENSE injectable regenerative graft is an osteoconductive bone graft which provides the benefits of injectability, hardness to support bone and predictable bone regeneration. Soft tissue repair products, such as its GRAFTJACKET regenerative tissue matrix, enable the repair of soft tissue such as tendons (e.g., rotator cuff and Achilles), ligaments or chronic wounds such as diabetic foot ulcers. The Company's products are strictly regulated by the FDA under the Food, Drug, and Cosmetic Act (FDC Act). Some of its products are also regulated by state agencies.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:WM3.Germany
ยป More Articles for WMGI

Headlines

Articles On GuruFocus.com
Wright Medical Group Inc. Reports Operating Results (10-Q) Oct 29 2010 
Wright Medical Group Inc. Reports Operating Results (10-Q) Aug 03 2010 
Wright Medical Group Inc. (WMGI) Sr. VP & CFO Lance A Berry sells 1,015 Shares May 19 2010 
Wright Medical Group Inc. (WMGI) President and CEO Gary D Henley sells 2,266 Shares May 19 2010 
Wright Medical Group Inc. (WMGI) President and CEO Gary D Henley sells 4,950 Shares May 17 2010 
Wright Medical Group Inc. (WMGI) Sr. VP & CFO Lance A Berry sells 1,260 Shares May 17 2010 
Wright Medical Group Inc. Reports Operating Results (10-Q) May 05 2010 
Wright Medical Group Inc. (WMGI) Exec. VP & CFO John K Bakewell sells 9,249 Shares Dec 04 2009 
Wright Medical Group Inc. Reports Operating Results (10-Q) Oct 30 2009 
Wright Medical Group Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Our Partners
Wright Medical Stays Neutral - Analyst Blog May 22 2013 - ZACKS

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial